Headings Clause Example from Business Contracts

This example Headings clause appears in 20 contracts from 18 companies

Headings. The Section headings are intended for convenience of reference only and are not intended to be a part of or to affect the meaning or interpretation of this Agreement.
Found in RenovoRx, Inc. contract
Cabaletta Bio, Inc. Contracts

Consulting Agreement between Tycho Therapeutics, Inc. and Danforth Advisors, LLC, Effective May 7, 2018 (Filed With SEC on September 30, 2019)

SYNLOGIC, INC. Contracts

Consulting Agreement between Synlogic Operating Company, Inc. and Danforth Advisors, LLC (Filed With SEC on October 24, 2019)

ADURO BIOTECH, INC. Contracts

Consulting Agreement between Aduro Biotech and Danforth Advisors, LLC (January 22, 2020) (Filed With SEC on January 23, 2020)

Spero Therapeutics, Inc. Contracts

Consulting Agreement between Spero Therapeutics, Inc. and Danforth Advisors, LLC (Filed With SEC on May 8, 2020)

Generation Bio Co. Contracts

Consulting Agreement between Generation Bio Co. and Danforth Advisors, LLC (Filed With SEC on May 22, 2020)

ORGANOVO HOLDINGS, INC. Contracts

Consulting Agreement between Organovo, Inc. and Multi Dimensional Bio Insight LLC (MDBI) (Filed With SEC on November 5, 2020)

Consulting Agreement between Organovo, Inc. and Danforth Advisors, LLC (August 25, 2020) (Filed With SEC on November 5, 2020)

Solid Biosciences Inc. Contracts

Consulting Agreement between Solid Biosciences Inc. and Danforth Advisors, LLC (November 19, 2020) (Filed With SEC on March 15, 2021)

Inozyme Pharma, Inc. Contracts

Amended and Restated Consulting Agreement between Inozyme Pharma, Inc. and Danforth Advisors, LLC (Filed With SEC on May 7, 2021)

Elicio Therapeutics, Inc. Contracts

Consulting Agreement between Vedantra Pharmaceuticals Inc. and Danforth Advisors, LLC (March 13, 2013) (Filed With SEC on June 28, 2021)

Aerpio Pharmaceuticals, Inc. Contracts

Consulting Agreement between Aadi Bioscience, Inc. and Danforth Advisors, LLC (Effective July 20, 2021) (Filed With SEC on August 27, 2021)

TENAX THERAPEUTICS, INC. Contracts

Consulting Agreement between Tenax Therapeutics, Inc. and Danforth Advisors, LLC (Filed With SEC on November 15, 2021)

Consulting Agreement between Tenax Therapeutics, Inc. and Danforth Advisors, LLC (Filed With SEC on March 29, 2022)

Arcellx, Inc. Contracts

Consulting Agreement between Arcellx, Inc. and Danforth Advisors, LLC (Effective January 7, 2022) (Filed With SEC on January 14, 2022)

Pulmatrix, Inc. Contracts

Consulting Agreement between Pulmatrix, Inc. and Danforth Advisors, LLC (Effective November 30, 2021) (Filed With SEC on April 15, 2022)

RenovoRx, Inc. Contracts

Consulting Agreement between RenovoRx, Inc. and Danforth Advisors, LLC dated April 25, 2022 (Filed With SEC on July 19, 2022)

HISTOGENICS CORP Contracts

Consulting Agreement between Histogenics Corporation and Danforth Advisors, LLC (Filed With SEC on December 21, 2018)

PROTEOSTASIS THERAPEUTICS, INC. Contracts

Consulting Agreement between Proteostasis Therapeutics, Inc. and Danforth Advisors, LLC (May 7, 2018) (Filed With SEC on August 8, 2018)

AIT Therapeutics, Inc. Contracts

Consulting Agreement between AIT Therapeutics, Inc. and Danforth Advisors, LLC (October 2, 2017) (Filed With SEC on May 7, 2018)

PIERIS PHARMACEUTICALS, INC. Contracts

Consulting Agreement between Pieris Pharmaceuticals, Inc. and Danforth Advisors, LLC (Filed With SEC on March 30, 2017)